Cipherome, Inc.
San Jose, CA, US· latest recorded location
Cipherome, Inc. is named on 3 US grants and 10 published applications in this corpus. Its most frequent classification is G16B (Bioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or).
- Granted patents
- 3
- Published applications
- 10
- Inventors
- 10
- Granted in 2026 so far
- 0
- Most recent grant
- 7 Dec 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 1 |
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 3 | 3 |
| 2022 | 0 | 1 |
| 2023 | 0 | 2 |
| 2024 | 0 | 1 |
By publication year.
Technology areas
Share of 13 documents
- G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or10
- C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms5
- G16CComputational chemistry5
- Y02ATechnologies for adaptation to climate change5
- G06FComputing and data processing4
- G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the4
- G06NAI and machine learning2
Recent patents
- Method for selecting anticancer agent based on protein damage information of individual to prevent anticancer agent side effects7 Dec 2021US 11,195,594 B2
- Method for personalized selection of a drug for a subject16 Mar 2021US 10,950,326 B2
- Secure communication of nucleic acid sequence information through a network19 Jan 2021US 10,896,743 B2
- Interoperable privacy-preserving distributed machine learning method for heterogeneous multi-center data11 Apr 2024US 2024/0119306 A1
- Health and medical history visualization and prediction using machine-learning and artificial intelligence models16 Nov 2023US 2023/0368879 A1
- Interoperable privacy-preserving multi-center distributed machine learning method for healthcare applications16 Nov 2023US 2023/0368926 A1
- Interactive user interface for providing treatment information10 Feb 2022US 2022/0044829 A1
- Prediction of adverse drug reaction based on machine-learned models using protein function scores and clinical factors21 Oct 2021US 2021/0327553 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.